Global Pharmaceuticals & Biotech High ROE Growth Engines

Incyte

Market Cap: US$23.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Exelixis

Market Cap: US$14.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Orion Oyj

Market Cap: €9.8b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥55.3b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥47.3b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Abbott India

Market Cap: ₹576.4b

Operates as a pharmaceutical company in India.

3SBio

Market Cap: HK$45.2b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹412.6b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

SK Biopharmaceuticals

Market Cap: ₩6.5t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥25.0b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

Xiamen Amoytop Biotech

Market Cap: CN¥22.7b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Zealand Pharma

Market Cap: DKK 19.8b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.3b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.5b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

HUTCHMED (China)

Market Cap: UK£1.4b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

HBM Holdings

Market Cap: HK$10.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

ChemoMetec

Market Cap: DKK 7.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Theravance Biopharma

Market Cap: US$880.0m

A biopharmaceutical company, develops and commercializes medicines in the United States.

Sanofi India

Market Cap: ₹78.5b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Oscotec

Market Cap: ₩1.2t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

CorMedix

Market Cap: US$680.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Middle East Pharmaceutical Industries

Market Cap: ر.س2.2b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

GlaxoSmithKline Pakistan

Market Cap: PK₨118.8b

A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.

Abeona Therapeutics

Market Cap: US$405.8m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Elite Pharmaceuticals

Market Cap: US$395.0m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Onconic Therapeutics

Market Cap: ₩531.3b

Engages in the research and development of anti-cancer therapy in South Korea.

Compugen

Market Cap: US$233.6m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Highnoon Laboratories

Market Cap: PK₨54.1b

Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.

Saniona

Market Cap: SEK 1.8b

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.

Oramed Pharmaceuticals

Market Cap: US$171.1m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Quality Chemical Industries

Market Cap: USh577.0b

Engages in the manufactures and sells pharmaceutical drugs in Uganda.

BLS Pharmaceuticals

Market Cap: AU$207.0m

Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan.

Hoechst Pakistan

Market Cap: PK₨38.8b

Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Vaxart

Market Cap: US$132.1m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.